You are here

  • Home
  • Archive
  • Volume 76, Issue 4
  • ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19

Article Text

Article menu
Download PDFPDF
Brief communication
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
  1. Swapna Mandal1,
  2. Joseph Barnett2,
  3. Simon E Brill1,
  4. Jeremy S Brown3,4,
  5. Emma K Denneny4,
  6. Samanjit S Hare2,
  7. Melissa Heightman4,
  8. Toby E Hillman4,
  9. Joseph Jacob5,6,
  10. Hannah C Jarvis1,
  11. Marc C I Lipman1,3,
  12. Sindhu B Naidu1,
  13. Arjun Nair6,
  14. Joanna C Porter3,4,
  15. Gillian S Tomlinson4,7,
  16. John R Hurst1,3
  17. ARC Study Group
    1. 1 Respiratory Medicine, Royal Free London NHS Foundation Trust, London, UK
    2. 2 Department of Radiology, Royal Free London NHS Foundation Trust, London, UK
    3. 3 UCL Respiratory, University College London, London, UK
    4. 4 Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, UK
    5. 5 Centre for Medical Image Computing, University College London, London, UK
    6. 6 Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK
    7. 7 Infection and Immunity, University College London, London, UK
    1. Correspondence to Professor John R Hurst, UCL Respiratory, University College London, London, London NW3 2PF, UK; j.hurst{at}ucl.ac.uk

    Abstract

    Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation.

    • viral infection
    • respiratory infection

    This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

    https://bmj.com/coronavirus/usage

    https://doi.org/10.1136/thoraxjnl-2020-215818

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      View Full Text

      Footnotes

      • Twitter @lungdiagnosis, @lungradiologist, @drjoporter

      • Collaborators The ARC Study Group: Aishah Ahmed, Asia Ahmed, Andrea Bangay, Izumi Barbor, Meg Barber, James Batty, Thea Buchan, Tom Burns, Alisha Chauhan, Ben Cooper, Roise Dudley, Mark Duncan, Nada Elsaid, Rebecca Evans, Samuel Flatau, Lydia Gabriel, James Goldring, Heather Groombridge, Liam Healy, Neel Jain, Afshan Khan, Camila Nagoda Niklewicz, Ezgi Ozcan, Preena Patel, Shivani Patel, Alexander Procter, Alice Ring, James Robertson, Portia Sagoe, Anita Saigal, George Seligmann, Runil Shah, Magali Taylor, Andrew Wendruff and Hannah Woodcock.

      • Contributors SM, SEB, JSB, MH, TEH, MCIL, JCP and JRH developed the clinical follow-up protocol. JB, JJ, SSH and AN developed and led the radiology protocols and analysis. SM, EKD, MH, HCJ, SBN and GST delivered and supported the follow-up process at three hospital sites. SM led the initial data analysis. JRH developed the first draft of the manuscript. All authors revised the manuscript for important intellectual content and approved the final version for submission.

      • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

      • Competing interests None declared.

      • Patient consent for publication Not required.

      • Provenance and peer review Not commissioned; externally peer reviewed.

      Linked Articles